Changes in vaccine approval have created confusion among consumers and industry leaders. Patrick Aguilar, MD, managing director of Olin Business School’s Business of Health initiative at Washington University in St. Louis, says these changes may also further strain the health sector, which makes up nearly 20% of the U.S. economy.